Transformative, instrument-free solution for single cell RNA sequencing updated with improved sensitivity, faster workflow
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced a significant update to the company’s flagship Evercode™ Whole Transcriptome products. Available to ship in mid-March, Evercode Whole Transcriptome version 3 kits offer...
The research demonstrates a breakthrough in applying quantum-enhanced generative AI to drug discovery using today’s quantum devices.
Zapata Computing, Inc., the Industrial Generative AI company, today announced that its scientists, in collaboration with Insilico Medicine, the University of Toronto, and St. Jude Children’s Research Hospital have demonstrated the first instance...
AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, and German independent research institute BioMed X, announced the launch of its latest global call for applications to identify computational biologists, biomedical scientists and inventors to form a new startup at AION...
Ardigen, a world-leading AI Contract Research Organization (AI CRO) at the forefront of the AI transformation in the biotech and pharmaceutical sectors, is thrilled to announce the appointment of Livia Legg as the Chief Commercial Officer. Livia will also join the company's Board of Management, bringing a wealth of leadership experience...
Saama announced the appointment of Bhaskar Sambasivan as Chief Executive Officer. Sambasivan succeeds Vivek Sharma, who is stepping down from his role for personal reasons after having successfully guided the company through a period of growth and expansion. An industry veteran within life sciences, Bhaskar brings a deep understanding...
Bioptimus will connect the different scales of biology with generative AI; from molecules to cells, tissues and whole organisms, to fuel scientific breakthroughs and accelerate innovation in biomedicine and beyond
French startup Bioptimus emerged from stealth following a seed funding round of $35M. Under the leadership of Professor Jean-Philippe Vert, PhD, Bioptimus...
AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients with locally advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) who have received prior systemic therapy. The Prescription Drug User Fee Act date, the...
Advances include faster and more robust protein structure prediction; higher-quality models of protein/protein interactions; large-scale screening and improved de novo protein design for therapeutics
OpenFold, a non-profit artificial intelligence (AI) research consortium, announced the release of two new tools: 1) SoloSeq, which integrates a new protein Large Language Model (LLM)...
InveniAI® LLC, a global leader in the application of artificial intelligence (AI) and machine learning (ML) tools to revolutionize drug discovery and development, announces a strategic collaboration with Ono Pharmaceutical Co., Ltd. (Ono), a renowned pharmaceutical company committed to advancing innovative solutions for unmet medical needs.
InveniAI's cutting-edge technology, including powerful...
Sequoia Biotech Consulting (Sequoia), a leading life sciences consulting firm renowned for its expertise in scaling life science organizations to deliver high-quality therapeutics, diagnostics, and medical devices, proudly announces the appointment of Kimberly Bennett as Chief Operating Officer (COO).
Having served as an invaluable member of Sequoia's executive leadership team for over...
